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Abstract 
The aim was to compare potential methods for fluoride analysis in microlitre-volume plasma samples 
containing nanogram amounts of fluoride. Methods: A group of 4 laboratories analysed a set of 
standardised biological samples as well as plasma to determine fluoride concentration using 3 
methods. In Phase-1, fluoride analysis was carried out using the established hexamethyldisiloxane 
(HMDS)-diffusion method (1 mL-aliquot/analysis) to obtain preliminary measurement of agreement 
between the laboratories. In Phase-2, the laboratories analysed the same samples using a micro-
diffusion method and known-addition technique with 200 μL aliquot/analysis. Coefficients of 
Variation (CVs) and intraclass correlation coefficients (ICCs) were estimated using analysis of 
variance to evaluate the amount of variation within- and between-laboratories. Based on the results of 
the Phase-2 analysis, 20 human plasma samples were analysed and compared using the HMDS-
diffusion method and known-addition technique in Phase-3. Results: Comparison of Phase-1 results 
showed no statistically significant difference among the laboratories for the overall data set. The mean 
between- and within-laboratory CVs and ICCs were < 0.13 and ≥0.99, respectively, indicating very 
low variability and excellent reliability. In Phase-2, the overall results for between-laboratory 
variability showed a poor CV (1.16) and ICC (0.44) for the micro-diffusion method, whereas with the 
known-addition technique the corresponding values were 0.49 and 0.83. Phase-3 results showed no 
statistically significant difference in fluoride concentrations of the plasma samples measured with 
HMDS-diffusion method and known addition technique, with a mean (SE) difference of 0.002 (0.003) 
μg/mL. In conclusion, the known-addition technique could be a suitable alternative for the 
measurement of fluoride in plasma with microlitre-volume samples. 
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Introduction 
It has been well established that topical fluoride (F) plays an important role in the prevention of dental 
caries. However, excessive systemic ingestion of F during enamel development prior to tooth eruption 
can in- crease the risk of development of dental fluorosis. Therefore, it is important to assess F 
exposure and retention in very young children on a regular basis using a suitable biomarker for F. The 
World Health Organisation has stated that “a fluoride biomarker is of value primarily for identifying 
and monitoring deficient or excessive intakes of biologically available fluoride” [World Health 
Organization, 1994]. For a biomarker to be suitable, it needs to be valid, reliable and practical in terms 
of collection and analysis with the practical aspects of sample collection being especially pertinent in 
young children. 
Following ingestion of F, the plasma F concentration increases rapidly, reaching its peak within 20–
60 min. Since the rise in plasma F concentration is proportional to F intake, plasma has been 
suggested as a reliable indicator of F exposure in humans. Additionally, from a pharmacokinetic 
perspective, plasma is considered the “central compartment” of F distribution systemically, since it is 
the fluid that F must pass into and then from – to be distributed around and eliminated from – the 
body [Whitford, 1996]. Despite the importance of plasma F for pharmacokinetic and analytical 
epidemiology studies, there is insufficient data on plasma F concentrations, particularly in children, 
to determine normal baseline values for individuals living in fluoridated and non-fluoridated 
communities with different degrees of F intake and expo- sure [Rugg-Gunn et al., 2011]. 
Pharmacokinetic and analytical epidemiology studies usually involve venous blood sampling by direct 
puncture to a vein, most often located in the antecubital area of the arm or the dorsal aspect (top) of 
the hand. In surveys involving measurements of several analytes in blood, the relatively large volumes 
of blood required may also be an insurmountable limitation. In addition, venous blood sampling is 
deemed ethically unacceptable or impractical in most studies with healthy young children. As a result, 
capillary blood is of- ten the method of choice for infants, very young children, and elderly patients 
with fragile veins, and is collected by dermal puncture of fingertip or heel.  
Determination of F in biological samples comprises several steps, which may include pre-treatment of 
samples, separation and concentration of F, actual measurement of F ions, calculation of final 
concentration per unit of sample, and presentation of the data [Venkateswarlu, 1990]. The most 
accurate sample preparation technique uses a diffusion method, such as acid-hexamethyldisiloxane 
(HMDS) diffusion [Taves, 1968] to separate F ion from the interfering substances in the sample and 
transfer it to a trapping solution of small volume to increase the final F concentration in the solution. 
The most frequently employed method for measurement of F involves the use of ion-selective 
electrode (ISE)-based potentiometric methods, which measure free F ions in aqueous solutions fairly 
quickly. Blood plasma contains 2 general forms of F: ionic (inorganic) and non-ionic (organic). The 
ionic form is the one of interest in dentistry, medicine, and public health [Whitford, 1996], which can 
be principally determined by F-ISE. 
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To optimise the quality of dental research involving F assay and minimise between-laboratories F 
analysis in- consistencies, standardised F analysis techniques have been developed and tested based 
on an HMDS-diffusion method using F-ISE [Martínez-Mier et al., 2011]. The techniques are used 
increasingly widely by laboratories undertaking F analysis of biological and non-biological samples, 
as they meet requirements for accuracy and reliability at a relatively low cost. 
In adult humans, plasma F concentration might be as low as 6.8 ng/mL [Buzalaf, 2011]. Considering 
the limit of sensitivity of the F-ISE, which is about 10–6 mol/L (= 0.02 µg/mL = 20 ng/mL) 
[Whitford, 1996], a minimum volume of 1,000 µL of plasma is required to ensure accept- able F 
measurement in duplicate (500 µL per replicate) using the gold standard HMDS diffusion method in 
which the F is concentrated in a 75–100 µL volume prior to analysis [Taves, 1968; Martínez-Mier et 
al., 2011]. The volume of plasma that can be obtained from a unit of whole blood is determined by the 
volume of blood collected and the donor percent haematocrit (% Hct). The theoretical range of plasma 
volume that can be recovered from a unit of whole blood is 40–60% [PALL Medical, 2010]. 
Therefore, a minimum of approximately 2 mL blood is needed for duplicate (or 3 mL for triplicate) 
plasma F analysis using the gold standard HMDS-diffusion method [Martínez-Mier et al., 2011]. 
Due to the importance of F research in dentistry, several F-ISE-based methodologies for sample 
manipulation and F analysis on very small sample volumes have been explored for measuring F in 
biological samples such as saliva, plasma and dental plaque (biofilm). Several techniques, including 
micropipette procedures for transfer- ring samples, preparation of micro F-ISE, and methods for 
adapting standard electrodes have been developed for various biological samples containing nano- or 
sub-nano-gram amounts of F [Hallsworth et al., 1976; Vogel et al., 1990]. Despite promising results 
with these methods for samples such as saliva, dental plaque and tooth enamel, they have not been 
widely employed due to their cost and time-consumption in addition to the need for careful attention 
to technique, which requires extensive experience. 
Using the relatively straightforward known-addition technique, Ekstrand [1977] reported a 
satisfactory reproducibility with 150 µL plasma samples containing ≥20 ng F. A rather simple micro-
diffusion technique, based on the gold standard HMDS-diffusion method, has also been developed for 
dental plaque [Martinez- Mier et al., 2010], which can easily be adapted for samples of plasma. 
Therefore, the aim of this study was to investigate the precision and accuracy of these 2 simple 
methods for F analysis in microlitre volume plasma samples containing nano- or sub-nano-gram 
amounts of F, in comparison with the gold standard HMDS-diffusion method. 
 
Material and Methods 
Four internationally recognised laboratories with track record expertise in F analysis participated in 
this study. The sites comprised University of Sao Paulo (Brazil), Newcastle University (UK), 
Teesside University (UK) and Indiana University (US). Each collaborative laboratory received a set 
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of samples comprising 5 F standards as Reference Materials (RMs), 4 samples of National Institute of 
Standards and Technology (NIST) traceable F standards, 2 samples of Urine Certified Reference 
Fluoride (UCRF) and 3 samples of freeze-dried powdered plasma samples. 
The 5 RMs with F concentrations of 0.01, 0.02, 0.06, 0.2 and 1.0 ppm were prepared from a certified 
100 ppm F standard (940907, Fisher Scientific) in one of the centres. The 4 NIST traceable standards 
were also prepared from a NIST-certified 10 ppm F solution at another centre. Samples of UCRF (PC-
U-F1703) were purchased from “Laboratoire de sante publique du Quebec” (QC H9X 3R5) and 
powdered plasma (P9523) from Sigma-Aldrich (Saint Louis, MO 63103, USA) by 1 centre. All the 
samples were prepared and/or purchased by staff who were not directly involved in sample analysis 
and labelled with a code. The blind-labelled samples were then distributed among the 4 collaborative 
laboratories. No specific preparation was used for RMs, NIST traceable standards or UCRFs in each 
laboratory. However, each vial of dried plasma was reconstituted with 5 mL deionised distilled water 
to produce 5 mL liquid plasma. All samples were stored in a freezer (–20 ° C) until F analysis. 
The study was then undertaken in 3 phases. In Phase 1, a between-laboratory comparison of the gold 
HMDS-diffusion method was conducted. The 4 collaborative laboratories analysed a set of samples (n 
= 14), in triplicate (1 mL sample per replicate), in order to obtain a preliminary measure of agreement 
between the laboratories. Within each laboratory, the samples were re-analysed on a separate day to 
obtain the within-laboratory agreement/reliability. In Phase 2, all 4 laboratories analysed the same set 
of samples as Phase 1 but in a lower volume (200 μL) using the micro-diffusion method as well as the 
known-addition technique. Detailed information regarding the 3 analytical methods (HMDS diffusion 
method, micro-diffusion method and known-addition technique) is available as online supplementary 
materials (see www.karger.com/10.1159/000492339).  
The results from the tests in Phases 1 and 2 were distributed to all laboratories and a review involving 
comparison of the 2 methods for F analysis was conducted by email and at a face-face meeting. 
According to the results, the choice of methods for Phase 3 was agreed upon among the laboratories. 
In Phase 3, the selected methods were used to analyse 20 human plasma samples by one laboratory. 
 
Statistical Analysis 
Sample Size 
The sample size calculation was based on the precision of the estimate of the within- and between-
laboratory intra-class correlation coefficients (ICCs). The samples were measured twice at each of the 
4 laboratories. With a sample size of n = 14 samples, the 95% lower confidence bound for the ICCs 
would extend, at most, 0.10 from the estimated ICCs, assuming that the within-laboratory ICCs were 
at least 0.90 and the between-laboratory ICCs were at least 0.75. 
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Statistical Analysis 
For plasma samples for which the F concentration was not certified, F standards and NIST traceable 
standards were evaluated for the amount of variation within- and between-laboratories using random 
effects analysis of variance models. The analysis of variances also provided estimates of the 
Coefficients of Variation (CVs) and ICCs. Pairwise comparisons among the laboratories were 
performed using a Tukey-Kramer adjustment for multiple comparisons. Analyses were performed 
using SAS version 9.3 (SAS Institute Inc., Cary, NC, USA).  
Trueness and precision testing of the agreed-upon methods were evaluated using the ISO Guide 32: 
Calibration in analytical chemistry and use of certified reference materials [1997] and the NIST 
Special Publication 829: Use of NIST traceable standards for decision on performance of analytical 
chemical methods and laboratories [Becker et al., 1992]. Trueness and between-laboratory precision 
were based on confidence intervals that use both the within- and between-laboratory error terms. The 
trueness and precision analyses included the plasma samples in addition to the F standards and NIST 
traceable standards. The F concentrations from the Phase 1 F analysis of the plasma samples were 
considered the reference values for comparison with the lower volume sample F analyses. 
Linear mixed effects models [Pinheiro and Bates, 2000] were used to determine the effects of assay 
method on the measured F concentration. Method, laboratory and true F concentration (i.e., actual 
expected known value) were used as fixed effects, while phase and day were treated as nested random 
effects. Separate mixed-effects intercept-only analyses were also undertaken on the difference 
between the measured and true F concentrations (ideally zero), with phase, laboratory and method as 
nested random effects. Quality of the fitted models was assessed by quantile-quantile plots (QQ-plot), 
residuals and predicted vs observed values. Analyses were undertaken in R using the nlme library 
[Pinheiro et al., 2017]. 
 
Results 
Table 1 presents the overall between- and within-laboratory variabilities in the F concentration of 
samples collectively, by method, when the results from all laboratories were pooled together. Overall, 
results for between laboratory variability showed a poor ICC of 0.44 for the micro-diffusion method 
but excellent ICCs for the HMDS-diffusion method (0.99) and the known-addition technique (0.83). 
There was also a poor CV of 1.162 for the micro-diffusion method, however, the between-laboratory 
variability showed an ICC of more than 0.75 (a cutoff point for an excellent agreement) for the 3 
methods. 
When looking at the overall data set, the comparison of the mean F concentration of all samples 
showed no statistically significant difference among the 4 laboratories when the samples were 
analysed by the HMDS-diffusion method as well as with the known-addition technique. However, the 
between-laboratory comparison of the mean F concentrations of all samples, measured by the micro-
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diffusion method, found a statistically significant (p = 0.05) difference in the measured F 
concentrations between Laboratories 1 and 3. 
The within-laboratory variation in the overall measured F concentration method is presented in Table 
2. The mean CVs for the laboratories were below 0.1, and the ICCs were above 0.96 with the gold 
standard HMDS diffusion method and the known-addition technique, whereas the ICC was as low as 
0.37 and CV as high as 0.671 with the micro-diffusion method. 
Comparison of the results for each individual sample among laboratories indicated statistically 
significant differences among the 4 laboratories for some samples (Table 3). For the HMDS-diffusion 
method, Laboratory 2 had statistically significantly (p = 0.04) lower F measurements than Laboratory 
4 for only 1 sample (RM-C, 0.06 ppmF) with a mean (SE) difference of –0.028 (0.002) μg/mL. The 
between-laboratory comparison of the results obtained by the micro-diffusion method and known-
addition technique revealed statistically significant differences obtained for certain samples (e.g., 
NIST-A, NISTD, NIST-C, URCF-2) among some laboratories as demonstrated in Table 3. 
The true F concentrations of all samples, apart from plasma, were known. Therefore, for each 
individual sample (apart from plasma), its measured F concentration by each of the 4 laboratories for 
each method were pooled and compared with its true (expected known) value (Fig. 1). Table 4 shows 
the results of the mixed-model analysis, comparing the measured F concentrations with the expected F 
concentration values, with laboratory and method as fixed effects and phase and day as nested random 
effects. The results showed a strong relationship between measured and true (expected known) F 
concentration values. However, there was a significant laboratory effect, with Laboratory 3 noticeably 
different from the other 3 laboratories. The comparison of the measured F concentration of the 3 low 
F concentration samples (i.e., 0.01, 0.02, and 0.06 μg/mL) with predicted values from the fitted 
model, across all the laboratories, showed that the predicted F concentrations by the known-addition 
were much closer to the values predicted by the established HMDS-diffusion method. The QQ-plots 
for the HMDS-diffusion method and known-addition technique gave approximately straight lines 
(Fig. 2), confirming the validity of the statistical models used in the analysis. 
Mean (SE) F concentrations of the 20 plasma samples, which were measured by the established gold 
standard method (i.e., HMDS-diffusion) and the known-addition technique were 0.040 (0.006) and 
0.038 (0.006) μg/mL respectively. The mean (SE) differences in F concentration between these 2 
methods was 0.002 (0.003) μg/mL, with a 95% CI of –0.005, +0.009 μg/mL, indicating a non-
statistically significant difference in the measured F concentrations between the 2 methods. 
 
Discussion 
Pharmacokinetic and analytical epidemiology studies, particularly in dentistry, often seek to assess F 
concentrations in very small volume plasma samples. In the current literature, there is very limited 
information available on the reliability of quantitative measures of F in microliter volume plasma 
samples containing nano- or sub-nanogram amounts of F. The current study quantified the reliability 
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of the measurement of F in microlitre volumes of plasma using micro-diffusion and known-addition 
techniques in comparison with the gold standard HMDS-diffusion method. 
The main purpose of carrying out F analysis of the samples using the established gold standard 
HMDS-diffusion method with a minimum sample volume of 1 mL per replicate, in the current study, 
was to (i) obtain a preliminary measure of agreement between the laboratories in determining F 
concentration of samples, and (ii) use as a gold standard method for assessment of the other 2 
methods. The comparison of the results obtained for each laboratory showed no statistically 
significant difference among the 4 laboratories for the overall data set (Table 3) as well as the 
majority of the individual samples including plasma and the other 2 low F concentration samples (i.e., 
RM A [0.01 μgF/mL] and RM B [0.02 μgF/mL]). This method also demonstrated an excellent 
between-laboratory ICC that ranged from 0.95 to 1.00 with a low CV ranging between 0.091 and 
0.198% as well as an excellent within-laboratory ICC (0.99–1.00) and low CV (0.022–0.047). 
Generally, the sensitivity of the ISE is limited by the Nernstian response slope per decade activity, 
which is almost  57 mV for the F-ISE. Therefore, the limit of sensitivity of the F-ISE is about 0.02 
μg/mL (= 1 μmol/L) which is at, or below, the expected F concentrations of human plasma samples. 
However, by using the HMDS diffusion process, the F of the original sample is quantitatively 
transferred to a smaller volume with higher F concentration, well above the limit of sensitively of the 
F-ISE [Whitford, 1996]. A recent study [Wang et al., 2017] suggested a universal ion detection 
method using an electronic integrated multi-electrode system (EIMES) that bypasses the Nernstian 
slope limit. The EIMES was specified to increase the Nernstian response slope from 57.3 mV for 
a single F electrode to 564.7 mV for EIMES-10 F electrodes, which consequently could record a 
miniscule change in the ion concentration, thereby improving the accuracy and precision of the 
measurements. 
The current study found an overall poor between-laboratory ICC (0.44) and CV (1.162) for the micro-
diffusion method when used to measure micro-litre volumes, indicating a low reliability and high 
variability with this method. The within-laboratory variation in the overall measured F concentrations 
using the micro-diffusion method revealed a wide range in ICC and CVs. The observed between-
laboratory differences in the present study are consistent with those of Martinez-Mier et al. [2011], 
who compared the F concentration of several biological samples reported by 9 laboratories. 
Differences in measured F concentration of samples between the laboratories have also been reported 
in a study that compared F concentration of water samples analysed by 9 laboratories and the 
laboratory at the South African Bureau of Standards in light of the implementation of water 
fluoridation in South Africa [Mthethwa and du Plessis, 2005]. 
Despite the overall poor performance of the micro-diffusion method in the current study, a low 
variability (CV, 0.044) and excellent reliability (ICC, 1.00) was found for Laboratory 4 where that 
method was developed and is routinely in use. These results highlight the importance of the 
experience held by the laboratories and its impact on the precision and accuracy of the analytical 
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method. These results confirm that the use of a protocol for F analysis of samples using the micro-
diffusion method, without participating in a training programme prior to adoption, might not yield 
accurate measurement of F in low volume plasma samples. 
When using the known-addition technique in the current study, the overall within-laboratory variation 
was very low (CVs ranging from 0.030 to 0.068) and the reliability was excellent (ICCs ranging from 
0.99 to 1.00). However, comparison of the results for each individual sample among laboratories 
indicated statistically significantly differences in F measurements, mainly for those samples with 
higher concentrations of F, among all 4 laboratories.  
The study results confirmed the established HMDS diffusion method as the most accurate method for 
low volume plasma samples. Although the known-addition technique performed better than the 
micro-diffusion method, it showed a tendency of underestimating F concentration of samples with 
higher F concentrations (> 0.06 mgF/L). At an F concentration of 0.02 μg/mL, the performance of the 
known-addition technique was similar to the established HMDS-diffusion method (Fig. 1), which was 
validated by the QQ-plots (Fig. 2). The QQplots for the HMDS-diffusion method and known-addition 
technique were straight, implying good agreement, whereas the micro-diffusion method showed a 
distinct S-shaped curve, suggesting it is not a reliable method for F measurements of low F 
concentration samples. The non-significant difference in F concentration between the plasma samples 
measured by the established gold standard method (i.e., HMDS-diffusion) and the known-addition 
technique, along with the narrow CI also support the reliability of the known-addition technique for 
measurement of F in plasma samples. 
In the current study, a 200 μL plasma sample was used for F determination and the F analysis of the 
plasma samples analysed in Phase 3 showed an F concentration of more than 0.020 μg/mL (= 20 
ng/mL) for all samples. A satisfactory reproducibility with 150 μL plasma samples containing ≥20 ng 
F has also been reported by Ekstrand [1977]. However, Ekstrand also noted that for samples 
containing < 20 ng F, a minimum volume of 500 μL plasma was required for F determination with 
reasonable accuracy. 
A simple and easy sampling technique, such as capillary sampling, is required for systematic 
determination of plasma F concentrations, particularly in children. A maximum blood volume of 19 
μL has been reported for 8–20 year olds when the blood samples were collected by capillary 
punctures using soft-touch finger pricking devices [Pacaud et al., 1996]. As a result, the amount of 
blood collected by capillary sampling might be insufficient for accurate and reliable F measurements. 
In conclusion, the findings of this study suggest that the known-addition technique could be an 
alternative option for measurement of F in plasma with microlitre volume (200 μL) samples. 
Although the method gives a satisfactory reliability with samples containing 0.01–0.06 μgF/mL, 
above a concentration of 0.06 μgF/mL, the method tends to underestimate F concentration of samples. 
More studies are needed to refine this method or develop other simple methods for F analysis in 
micro-litre volume plasma samples containing nano- or sub-nano-gram amounts of F. 
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Table 1. Between- and within-laboratory variability for pooled mean (SD) F concentration (μg/mL), 
combined across all laboratories, by method of analysis 
 HMDS-diffusion Micro-diffusion Known-addition 
Between-laboratory    
Mean (SD) 0.367 (0.047) 0.324 (0.376) 0.277 (0.135) 
ICC (95% CI) 0.99 (0.95-1.00) 0.44 (0.05-0.77) 0.83 (0.54-0.94) 
CV (95% CI) 0.129 (0.091-0.198) 1.162 (0.633-∞) 0.487 (0.325-0.853) 
Within-laboratory    
Mean (SD) 0.367 (0.011) 0.324 (0.036) 0.277 (0.013) 
ICC (95% CI) 1.00 (0.99-1.00) 0.97 (0.86-0.99) 1.00 (0.98-1.00) 
CV (95% CI) 0.031 (0.022-0.047) 
0.111 (0.078-
0.169) 
0.047 (0.033-0.072) 
HMDS, hexamethyldisiloxane; ICC, intra-class correlation coefficient; CV, coefficient of variation. 
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Table 2. Mean (SD) and Within-laboratory variability in the overall F concentration (µg/ml) according to analytical method 
Lab 
Method 
HMDS-diffusion  Micro-diffusion  Known-addition 
Mean 
(SD) 
ICC 
(95% CI) 
CV 
(95% CI) 
 Mean 
(SD) 
ICC 
(95% CI) 
CV 
(95% CI) 
 Mean 
(SD) 
ICC 
(95% CI) 
CV 
(95% CI) 
1 
0.358 
(0.035) 
0.96 
(0.82-0.99) 
0.097 
(0.068-0.148) 
 0.072 
(0.048) 
0.37 
(0.00-0.81) 
0.671 
(0.428-1.406) 
 0.249 
(0.007) 
1.00 
(0.99-1.00) 
0.030 
(0.021-0.045) 
2 
0.381 
(0.007) 
1.00 
(1.00-1.00) 
0.018 
(0.012-0.027) 
 0.239 
(0.041) 
0.89 
(0.59-0.97) 
0.171 
(0.120-0.263) 
 0.322 
(0.016) 
1.00 
(0.98-1.00) 
0.049 
(0.035-0.075) 
3 
0.368 
(0.015) 
1.00 
(0.99-1.00) 
0.040 
(0.028-0.060) 
 0.629 
(0.059) 
0.84 
(0.44-0.96) 
0.093 
(0.066-0.142) 
 0.371 
(0.025) 
0.99 
(0.96-1.00) 
0.068 
(0.048-0.103) 
4 
0.358 
(0.008) 
1.00 
(1.00-1.00) 
0.023 
(0.016-0.035) 
 0.355 
(0.016) 
1.00 
(0.98-1.00) 
0.044 
(0.031-0.067) 
 0.165 
(0.009) 
1.00 
(0.98-1.00) 
0.053 
(0.037-0.081) 
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Table 3. Comparison of the results for each individual sample* among laboratories by method 
Method Sample Laboratory 
Mean (SE) 
Between-laboratory 
difference 
P value 
HMDS-diffusion RM-C 2 vs. 4 -0.028 (0.002) 0.04 
Micro-diffusion 
NIST-D 
1 vs. 3 -2.162 (0.146) 0.04 
1 vs. 4 -1.011 (0.075) 0.05 
Plasma-2 
1 vs. 3 -0.019 (0.001) 0.02 
1 vs. 4 -0.012 (0.001) 0.02 
UCRF-2 
1 vs. 3 -0.417 (0.033) 0.04 
2 vs. 3 -0.274 (0.022) 0.04 
Known-addition 
NIST-A 
1 vs. 2 -0.125 (0.007) 0.005 
1 vs. 3 -0.181 (0.007) 0.002 
1 vs. 4 0.106 (0.008) 0.01 
2 vs. 3 -0.056 (0.008) 0.04 
2 vs. 4 0.231 (0.009) 0.002 
3 vs. 4 0.287 (0.009) 0.001 
NIST-B 
1 vs. 4 0.231 (0.013) 0.04 
2 vs. 4 0.446 (0.025) 0.04 
NIST-C 
1 vs. 2 -0.127 (0.009) 0.03 
1 vs. 3 -0.178 (0.017) 0.05 
1 vs. 4 0.115 (0.007) 0.03 
2 vs. 4 0.242 (0.008) 0.01 
3 vs. 4 0.293 (0.017) 0.03 
NIST-D 
1 vs. 4 0.253 (0.016) 0.04 
2 vs. 4 0.462 (0.020) 0.03 
Plasma-3 2 vs. 4 0.018 (0.001) 0.03 
RM-E 3 vs. 4 0.636 (0.047) 0.04 
UCRF-2 
1 vs. 3 -0.094 (0.007) 0.04 
1 vs. 4 0.060 (0.006) 0.05 
* The samples with no statistically significant between-laboratory differences in their measured F 
concentration are not presented 
HMDS, hexamethyldisiloxane; RM, reference material; NIST, National Institute of Standards and 
Technology; UCRF, Urine Certified Reference Fluoride.
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Table 4. Comparison of the measured F concentrations with the true (expected) F concentration values 
using the mixed-model analysis. 
Variable Statistic P- value 
Intercept F1,158 = 89.18 <0.0001 
True Expected F concentration F1,158 = 221.85 <0.0001 
Method F2,158 = 0.26 0.7727 
Laboratory F3,158 = 9.01 <0.0001 
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Figure 1. Comparison of overall measured and true expected F concentration by analytical method across 
all laboratories (the horizontal line shows the true expected values).A: Gold standard HMDS-diffusion 
method; B: Micro-diffusion method; C: Known-addition Technique 
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Figure 2. The QQ-plots for gold standard HMDS-diffusion method (A), micro-diffusion method (B) and 
known-addition Technique (C) for the samples RM-A (0.01 µgF/ml), RM-B (0.02 µgF/ml) and RM-C 
(0.06 µgF/ml) across all laboratories. 
 
